These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31466114)

  • 21. Predictors of response to group cognitive-behavioral therapy in the treatment of obsessive-compulsive disorder.
    Raffin AL; Guimarães Fachel JM; Ferrão YA; Pasquoto de Souza F; Cordioli AV
    Eur Psychiatry; 2009 Jun; 24(5):297-306. PubMed ID: 19200694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
    Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of exposure and response prevention in obsessive-compulsive disorder: effects of habituation and expectancy violation on short-term outcome in cognitive behavioral therapy.
    Elsner B; Jacobi T; Kischkel E; Schulze D; Reuter B
    BMC Psychiatry; 2022 Jan; 22(1):66. PubMed ID: 35086513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congruence and discrepancy between self-rated and clinician-rated symptom severity on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) before and after a low-intensity intervention.
    Hauschildt M; Dar R; Schröder J; Moritz S
    Psychiatry Res; 2019 Mar; 273():595-602. PubMed ID: 30716599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial.
    Benazon NR; Ager J; Rosenberg DR
    Behav Res Ther; 2002 May; 40(5):529-39. PubMed ID: 12038645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial.
    Kyrios M; Ahern C; Fassnacht DB; Nedeljkovic M; Moulding R; Meyer D
    J Med Internet Res; 2018 Aug; 20(8):e242. PubMed ID: 30089607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Can the efficacy of behavioral and cognitive therapy for obsessive compulsive disorder be augmented by innovative computerized adjuvant?].
    Morgiève M; N'Diaye K; Clair AH; Pelissolo A; Mallet L
    Encephale; 2016 Oct; 42(5):402-409. PubMed ID: 27109326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical remission of a treatment-refractory individual with severe repetitive rituals and rumination.
    Sang DE; Shi LJ; Yue KC; He CY; Zhao HZ; Wang CH; Hu XZ
    Asian J Psychiatr; 2020 Jan; 47():101878. PubMed ID: 31756555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimensional structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS).
    Moritz S; Meier B; Kloss M; Jacobsen D; Wein C; Fricke S; Hand I
    Psychiatry Res; 2002 Mar; 109(2):193-9. PubMed ID: 11927144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.
    Rufer M; Hand I; Alsleben H; Braatz A; Ortmann J; Katenkamp B; Fricke S; Peter H
    Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):121-8. PubMed ID: 15812606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder: study protocol for a randomized controlled trial.
    Melchior K; Franken I; Deen M; van der Heiden C
    Trials; 2019 May; 20(1):277. PubMed ID: 31109349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Larson MJ; Geffken GR; Lehmkuhl HD; Jacob ML; Murphy TK; Goodman WK
    J Am Acad Child Adolesc Psychiatry; 2008 May; 47(5):583-592. PubMed ID: 18356759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder.
    Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC
    J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of alexithymia in obsessive-compulsive patients treated with multimodal cognitive-behavioral therapy.
    Rufer M; Hand I; Braatz A; Alsleben H; Fricke S; Peter H
    Psychother Psychosom; 2004; 73(2):101-6. PubMed ID: 14767152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of mindfulness-based cognitive therapy in patients with obsessive-compulsive disorder and residual symptoms after cognitive behavioral therapy: Twelve-month follow-up of a randomized controlled trial.
    Cludius B; Landmann S; Rose N; Heidenreich T; Hottenrott B; Schröder J; Jelinek L; Voderholzer U; Külz AK; Moritz S
    Psychiatry Res; 2020 Sep; 291():113119. PubMed ID: 32534361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
    Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
    Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of cognitive behavioral group psychotherapy for obsessive-compulsive disorder.
    Safak Y; Karadere ME; Ozdel K; Ozcan T; Türkçapar MH; Kuru E; Yücens B
    Turk Psikiyatri Derg; 2014; 25(4):225-33. PubMed ID: 25487620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Larson MJ; Bloss CS; Geffken GR; Jacob ML; Murphy TK; Goodman WK
    Acta Psychiatr Scand; 2008 Jan; 117(1):67-75. PubMed ID: 17986317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orbito-frontal cortex and thalamus volumes in the patients with obsessive-compulsive disorder before and after cognitive behavioral therapy.
    Atmaca M; Yildirim H; Yilmaz S; Caglar N; Mermi O; Korkmaz S; Akaslan U; Gurok MG; Kekilli Y; Turkcapar H
    Int J Psychiatry Med; 2018 Jul; 53(4):243-255. PubMed ID: 26740455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.